USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Galenea Corporation
Address:
300 Technology Square
CAMBRIDGE, MA 02139-
Phone:
(530) 545-1999
URL:
N/A
EIN:
450519414
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,712,079.00 3

Award List:

Development of siRNAs to Prevent and Treat Influenza

Award Year / Program / Phase:
2005 / SBIR / Phase I
Award Amount:
$383,410.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Influenza A virus causes one of the most wide-spread infections in humans. It is also a possible bioterrorism agent. In a typical year, it infects 10-20% of the population in the US, causing up to 40,000 deaths. During the 1918 influenza virus pandemic, over 40… More

Novel serotonergic, pro-cognitive antipsychotic therapies

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$699,792.00
Agency:
HHS
Principal Investigator:
Silvana Leit – 617-374-1010
Abstract:
DESCRIPTION (provided by applicant): This application, Novel serotonergic, pro-cognitive antipsychotic therapies , is in response to PA-08-142: Pharmacologic Agents and Drugs for Mental Disorders (SBIR [R43/R44]). Schizophrenia is a devastating brain disorder that affects approximately 0.7% of… More

In vitro tools for preclinical analysis of cognitive therapies for schizophrenia

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$628,877.00
Agency:
HHS
Principal Investigator:
Jonathan M. Levenson – 617-945-9763
Abstract:
DESCRIPTION (provided by applicant): Schizophrenia is a debilitating disease that afflicts 1% of the US population. Symptoms of schizophrenia are classified into three categories: positive (delusions and hallucinations), negative (flattened affect, socialisolation) and cognitive (impaired attention,… More